000 | 00837 a2200241 4500 | ||
---|---|---|---|
005 | 20250517204034.0 | ||
264 | 0 | _c20190418 | |
008 | 201904s 0 0 eng d | ||
022 | _a1876-7605 | ||
024 | 7 |
_a10.1016/j.jcin.2017.12.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKandzari, David E | |
245 | 0 | 0 |
_aThe Day After a Primary Endpoint. _h[electronic resource] |
260 |
_bJACC. Cardiovascular interventions _c03 2018 |
||
300 |
_a470-472 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aDrug-Eluting Stents |
650 | 0 | 4 | _aEverolimus |
650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
650 | 0 | 4 | _aStents |
773 | 0 |
_tJACC. Cardiovascular interventions _gvol. 11 _gno. 5 _gp. 470-472 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcin.2017.12.008 _zAvailable from publisher's website |
999 |
_c28159654 _d28159654 |